F
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G61.3 KBFlexion Therapeutics IncNov 23, 6:54 PM ET·0000905718-21-001525
- 8-K392.5 KBFlexion Therapeutics IncNov 19, 9:26 AM ET·0001104659-21-141653
- 10-Q11.8 MBFlexion Therapeutics IncNov 12, 4:07 PM ET·0000950170-21-004377
- SC 13G/A3.9 KBFlexion Therapeutics IncNov 9, 3:34 PM ET·0000814133-21-000100
- 8-K1.5 MBFlexion Therapeutics IncOct 12, 6:02 AM ET·0001104659-21-124870
- 10-Q9.9 MBFlexion Therapeutics IncAug 4, 4:06 PM ET·0000950170-21-000785
- 8-K856.5 KBFlexion Therapeutics IncAug 4, 4:02 PM ET·0000950170-21-000784
- 8-K158.5 KBFlexion Therapeutics IncJul 12, 5:00 PM ET·0000950170-21-000448
- 8-K184.0 KBFlexion Therapeutics IncJun 25, 4:02 PM ET·0000950170-21-000394
- 10-Q8.7 MBFlexion Therapeutics IncMay 12, 4:05 PM ET·0001564590-21-026980
Insiders
10- Andrews William T.Chief Medical Officer
- Arkowitz DavidChief Financial Officer
- ATWOOD BRIAN GDirector, 10% Owner
- Bodick NeilChief Medical Officer
- Bolzon Bradley J PhDDirector, 10% Owner
- Canute Scott ADirector
- Clayman Michael D.Director, President and CEO
- COLELLA SAMUEL DDirector, 10% Owner
- Deniz YamoChief Medical Officer
- DRISCOLL FREDERICK WChief Financial Officer
Tickers
No tickers on record
Addresses
business
10 MALL ROAD SUITE 301
BURLINGTON, MA, 01803
mailing
10 MALL ROAD SUITE 301
BURLINGTON, MA, 01803